Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PanGenex
Holmdel, New Jersey, United Statespangenex.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
PanGenex was a development-stage life sciences company primarily focused on the commercialization of proprietary, patent-protected nutraceuticals and functional foods. The company's lead product was Provinal, a highly purified palmitoleic acid (Omega-7) designed to address cardiovascular health by reducing systemic inflammation and improving lipid profiles. PanGenex targeted conditions such as metabolic syndrome and type 2 diabetes through its focus on C-reactive protein reduction. The company's assets and intellectual property were eventually integrated into Tersus Life Sciences, which continues to market the Provinal brand.
- Therapeutic areas
- EndocrinologyCardiovascularImmunologyMetabolic Disorders
- Modalities
- Small moleculeNutraceuticals
- Industry
- Food & Nutrition
02
Partnerships
Tersus Life Sciences
Beyond the preview
Go deeper on PanGenex.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PanGenex.